Zacks Research Issues Pessimistic Forecast for A Earnings

Agilent Technologies, Inc. (NYSE:A) – Equities researchers at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Agilent Technologies in a report released on Monday, February 24th. Zacks Research analyst R. Department now anticipates that the medical research company will earn $1.26 per share for the quarter, down from their previous estimate of $1.27. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.56 per share. Zacks Research also issued estimates for Agilent Technologies’ Q1 2026 earnings at $1.35 EPS.

Other research analysts have also recently issued research reports about the company. Citigroup increased their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Sanford C. Bernstein cut their price objective on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. Finally, Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $144.38.

Agilent Technologies Price Performance

Shares of NYSE A opened at $134.51 on Wednesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The stock has a fifty day moving average price of $140.90 and a 200 day moving average price of $139.28. Agilent Technologies has a 1-year low of $124.16 and a 1-year high of $155.35. The company has a market cap of $38.37 billion, a PE ratio of 30.43, a P/E/G ratio of 3.66 and a beta of 1.07.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion.

Institutional Trading of Agilent Technologies

A number of hedge funds have recently added to or reduced their stakes in A. Norges Bank acquired a new position in shares of Agilent Technologies in the 4th quarter valued at about $456,963,000. Madison Investment Advisors LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at about $94,051,000. Two Sigma Investments LP increased its holdings in Agilent Technologies by 345.9% during the 4th quarter. Two Sigma Investments LP now owns 769,897 shares of the medical research company’s stock worth $103,428,000 after purchasing an additional 597,249 shares during the last quarter. Iron Triangle Partners LP purchased a new stake in Agilent Technologies during the 4th quarter worth approximately $80,110,000. Finally, Marshall Wace LLP increased its holdings in Agilent Technologies by 280.3% during the 4th quarter. Marshall Wace LLP now owns 806,895 shares of the medical research company’s stock worth $108,398,000 after purchasing an additional 594,744 shares during the last quarter.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is presently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.